Target type: biologicalprocess
The process by which the mitochondrial outer membrane becomes permeable to the passing of proteins and other molecules from the intermembrane space to the cytosol as part of the apoptotic signaling pathway. [GOC:BHF, GOC:mtg_apoptosis, GOC:pg, PMID:21041309]
Mitochondrial outer membrane permeabilization (MOMP) is a crucial step in apoptosis, the programmed cell death pathway. It marks the point of no return, committing the cell to death. MOMP involves the formation of pores in the outer membrane of mitochondria, allowing the release of pro-apoptotic proteins such as cytochrome c, Smac/DIABLO, and AIF, into the cytosol.
The process is primarily regulated by the Bcl-2 family of proteins, which act as gatekeepers of MOMP. Pro-apoptotic Bcl-2 proteins, like Bax and Bak, oligomerize and insert into the outer membrane, forming the pores. Anti-apoptotic Bcl-2 proteins, like Bcl-2 and Bcl-xL, inhibit this process by binding to pro-apoptotic proteins and preventing their activation.
Several stimuli can trigger MOMP, including:
* **Intrinsic pathway**: Initiated by intracellular stress signals such as DNA damage, growth factor deprivation, or reactive oxygen species (ROS). This pathway involves the activation of pro-apoptotic proteins like Bax and Bak through a complex interplay of other proteins.
* **Extrinsic pathway**: Triggered by external signals like death receptors (e.g., TNFα receptor). This pathway activates caspase-8, which then activates Bid, a pro-apoptotic protein, leading to MOMP.
Following MOMP, cytochrome c released from the mitochondria interacts with Apaf-1 and procaspase-9 in the cytosol, leading to the formation of the apoptosome. The apoptosome activates caspase-9, triggering a cascade of caspase activation that ultimately leads to cell death.
The Smac/DIABLO and AIF released during MOMP also contribute to apoptosis by inhibiting anti-apoptotic proteins and activating caspase-independent pathways, respectively.
MOMP is tightly regulated to ensure that apoptosis occurs only when necessary and that the process is controlled. Dysregulation of MOMP can contribute to various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
BH3-interacting domain death agonist | A BH3-interacting domain death agonist that is encoded in the genome of human. [PRO:WCB, UniProtKB:P55957] | Homo sapiens (human) |
Voltage-dependent anion-selective channel protein 2 | A voltage-dependent anion-selective channel protein 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:P45880] | Homo sapiens (human) |
Eyes absent homolog 2 | An eyes absent homolog 2 that is encoded in the genome of human. [PRO:DNx, UniProtKB:O00167] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
benzbromarone | benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication. Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout. | 1-benzofurans; aromatic ketone | uricosuric drug |
beta-glycerophosphoric acid | beta-glycerophosphoric acid: plays role in mineralization of bone in vitro glycerol 2-phosphate : A glycerol monophosphate having the phosphate group at the 2-position. | glycerol monophosphate | Escherichia coli metabolite; plant metabolite |
gossypol | Gossypol: A dimeric sesquiterpene found in cottonseed (GOSSYPIUM). The (-) isomer is active as a male contraceptive (CONTRACEPTIVE AGENTS, MALE) whereas toxic symptoms are associated with the (+) isomer. | ||
sodium fluoride | fluoride salt | mutagen | |
edetic acid | Edetic Acid: A chelating agent that sequesters a variety of polyvalent cations such as CALCIUM. It is used in pharmaceutical manufacturing and as a food additive. | ethylenediamine derivative; polyamino carboxylic acid; tetracarboxylic acid | anticoagulant; antidote; chelator; copper chelator; geroprotector |
epigallocatechin gallate | (-)-epigallocatechin 3-gallate : A gallate ester obtained by the formal condensation of gallic acid with the (3R)-hydroxy group of (-)-epigallocatechin. epigallocatechin gallate: a steroid 5alpha-reductase inhibitor and antimutagen in green tea (Camellia sinensis) | flavans; gallate ester; polyphenol | antineoplastic agent; antioxidant; apoptosis inducer; geroprotector; Hsp90 inhibitor; neuroprotective agent; plant metabolite |
aminoquinuride | |||
6-n-tridecylsalicylic acid | 6-n-tridecylsalicylic acid: structure given in first source | hydroxybenzoic acid | |
5,6-dehydrokawain | 5,6-dehydrokawain: from Alpinia speciosa rhizoma; RN given for cpd without isomeric designation; structure given in first source | 2-pyranones; aromatic ether | |
erastin | erastin : A member of the class of quinazolines that is quinazolin-4(3H)-one in which the hydrogens at positions 2 and 3 are replaced by 1-{4-[(4-chlorophenoxy)acetyl]piperazin-1-yl}ethyl and 2-ethoxyphenyl groups, respectively. It is an inhibitor of voltage-dependent anion-selective channels (VDAC2 and VDAC3) and a potent ferroptosis inducer. erastin: an antineoplastic agent; structure in first source | aromatic ether; diether; monochlorobenzenes; N-acylpiperazine; N-alkylpiperazine; quinazolines; tertiary carboxamide | antineoplastic agent; ferroptosis inducer; voltage-dependent anion channel inhibitor |
abt-737 | aromatic amine; aryl sulfide; biphenyls; C-nitro compound; monochlorobenzenes; N-arylpiperazine; N-sulfonylcarboxamide; secondary amino compound; tertiary amino compound | anti-allergic agent; anti-inflammatory agent; antineoplastic agent; apoptosis inducer; B-cell lymphoma 2 inhibitor | |
meiogynin a | meiogynin A: from the bark of Meiogyne cylindrocarpa; structure in first source | ||
apogossypolone | apogossypolone: has antineoplastic activity; structure in first source |